IPO registrations (S-1, F-1) · Registrants
Tevogen Inc.
- SEC CIK
- 1860871 · filings on EDGAR ↗
- Name on the registration
- Tevogen Bio Holdings Inc.
- Former names
- Tevogen Bio Holdings Inc. (2024–2026); Semper Paratus Acquisition Corp (2021–2024)
- Registration
- Form S-1, first filed 2021-10-07, last 2024-08-01; 2 initial registrations, 6 amendments
- Outcome
- Final prospectus filed 2021-11-05; declared effective 2021-11-03
- Industry (SIC)
- Biological Products, (No Diagnostic Substances) 2836
- Incorporated in
- DE
- Business address
- 15 INDEPENDENCE BOULEVARD, SUITE #210, Warren, NJ 07059
- EIN
- 98-1597194
- Ticker
- TVGN, TVGNW (Nasdaq, Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- Tevogen Inc. on the corporate pages
Offering terms
- Final price
- $10.00 per share (424B4 filed 2021-11-05, an initial public offering)
- Shares sold
- 30,000,000
- Gross proceeds
- $300,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol LGST
- Lead underwriters
- Cantor Fitzgerald (30,000,000 shares)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- SEC filer: Semper Paratus Acquisition Corp EXACT (CIK (EXACT))
Filings 15
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2021-10-07 | S-1 | S-1 (registration) | Semper Paratus Acquisition Corp | 0001104659-21-124178 ↗ |
| 2021-10-22 | S-1/A | S-1/A (amendment) | Semper Paratus Acquisition Corp | 0001104659-21-129086 ↗ |
| 2021-10-26 | S-1/A | S-1/A (amendment) | Semper Paratus Acquisition Corp | 0001104659-21-130064 ↗ |
| 2021-10-27 | S-1/A | S-1/A (amendment) | Semper Paratus Acquisition Corp | 0001104659-21-130391 ↗ |
| 2021-10-29 | S-1/A | S-1/A (amendment) | Semper Paratus Acquisition Corp | 0001104659-21-131285 ↗ |
| 2021-11-03 | EFFECT | EFFECT (declared effective) | Semper Paratus Acquisition Corp | 9999999995-21-004173 ↗ |
| 2021-11-05 | 424B4 | 424B4 (final prospectus) | Semper Paratus Acquisition Corp | 0001104659-21-135071 ↗ |
| 2024-01-04 | EFFECT | EFFECT (declared effective) | Semper Paratus Acquisition Corp | 9999999995-24-000042 ↗ |
| 2024-06-21 | S-1 | S-1 (registration) | Tevogen Bio Holdings Inc. | 0001493152-24-024790 ↗ |
| 2024-07-23 | S-1/A | S-1/A (amendment) | Tevogen Bio Holdings Inc. | 0001493152-24-028834 ↗ |
| 2024-08-01 | S-1/A | S-1/A (amendment) | Tevogen Bio Holdings Inc. | 0001493152-24-029808 ↗ |
| 2024-08-02 | EFFECT | EFFECT (declared effective) | Tevogen Bio Holdings Inc. | 9999999995-24-002368 ↗ |
| 2025-05-02 | EFFECT | EFFECT (declared effective) | Tevogen Bio Holdings Inc. | 9999999995-25-001383 ↗ |
| 2025-06-26 | EFFECT | EFFECT (declared effective) | Tevogen Bio Holdings Inc. | 9999999995-25-002044 ↗ |
| 2026-06-25 | EFFECT | EFFECT (declared effective) | Tevogen Bio Holdings Inc. | 9999999995-26-002124 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2021-10-29 | S-1/A | registration statement | $10.00 | - | - | 0 | primary document; price sentence | document ↗ | ||
| 2021-11-05 | 424B4 | final prospectus | $10.00 | 30,000,000 | $300,000,000 | Nasdaq LGST | 1 | primary document; price sentence, shares headline, proceeds table, underwriting table 1, cover names 1 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| BALDANZA B BEN | Officer | Chief Executive Officer | 1 | 2021 | |
| Jebely Paul P | Director | 2 | 2021 | ||
| Kurzweil Philippe J | Officer | CFO & Secretary | 1 | 2021 | |
| Olver Parizad | Director | 1 | 2021 | ||
| Peretz Richard N. | Director | 1 | 2021 | ||
| Rogers Jeff | Officer | President | 1 | 2021 | |
| Semper Paratus Sponsor LLC | TenPercentOwner | 4 | 2021–2023 | ||
| Stewart Brad | Director | 1 | 2021 | ||
| Corbin Capital Partners GP, LLC | TenPercentOwner | 2 | 2023 | ||
| Corbin Capital Partners, L.P. | TenPercentOwner | 2 | 2023 | ||
| Corbin ERISA Opportunity Fund, Ltd. | TenPercentOwner | 2 | 2023 | ||
| AJJARAPU SURENDRA K | Director,Officer; Director,Officer,TenPercentOwner | CEO and Chairman | 3 | 2023 | |
| Wadhwani Avinash R | Director | 2 | 2023 | ||
| Fell Donald G. | Director | 1 | 2023 | ||
| Francis Knuettel II | Officer | Chief Financial Officer | 1 | 2023 | |
| PETERSON MICHAEL L | Director | 1 | 2023 | ||
| SSVK Associates, LLC | TenPercentOwner | 2 | 2023 | ||
| Sussman Scott Harris | Director | 1 | 2023 | ||
| Desai Kirti | Officer | Chief Financial Officer | 7 | 2024–2026 | |
| Feike Jeffrey L. | Director | 5 | 2024–2026 | ||
| Flomenberg Neal | Officer | Chief Scientific Officer; See Remarks | 8 | 2024–2026 | |
| Goh Keow Lin | Director | 5 | 2024–2026 | ||
| Khan Sadiq | Officer | Chief Commercial Officer | 3 | 2024–2025 | |
| Patton Curtis L. | Director | 5 | 2024–2026 | ||
| PODLOGAR SUSAN M | Director | 5 | 2024–2026 | ||
| Saadi Ryan H. | Director,Officer,TenPercentOwner | Chief Executive Officer | 10 | 2024–2026 | |
| Sordillo Victor J. | Director | 5 | 2024–2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| SEC filer | Tevogen Inc. | SEC filers (EDGAR) | CIK (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Biological Products, (No Diagnostic Substances), NJ first:
- IGX CORP/DE NJ
- ADMA BIOLOGICS, INC. NJ
- Point of Care Nano-Technology, Inc. NJ
- Outlook Therapeutics, Inc. NJ
- Oyster Point Pharma, Inc. NJ
- Kalaris Therapeutics, Inc. NJ
- TAMIR BIOTECHNOLOGY, INC. NJ
- GENTA INC DE/ NJ
- BioNTech SE 2M
- Immatics N.V. 2M
In other datasets, the same topic (Health) in NJ:
- Nonprofit: 1ST CEREBRAL PALSY OF NEW JERSEY INC (Nonprofits (IRS Form 990))
Interests: Biological Products, (No Diagnostic Substances) · Health